Wellington Management Group LLP Amneal Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $88,906 - $131,735	-29,537 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $102,921 - $129,047	-26,390 Reduced 47.19%	29,537 $123,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $6,067 - $8,081	1,185 Added 2.16%	55,927 $286,000
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $65.7 Million - $102 Million	-13,851,674 Reduced 99.61%	54,742 $369,000
Q4 2020 Feb 12, 2021	SELL	$3.95 - $5.42 $5.94 Million - $8.15 Million	-1,504,609 Reduced 9.76%	13,906,416 $63.6 Million

Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $253,354 - $377,168	71,569 Added 0.47%	15,411,025 $59.8 Million
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $44,792 - $85,214	15,607 Added 0.1%	15,339,456 $73 Million
Q1 2020 May 14, 2020	SELL	$2.46 - $5.35 $500,863 - $1.09 Million	-203,603 Reduced 1.31%	15,323,849 $53.3 Million
Q4 2019 Feb 11, 2020	BUY	$2.65 - $5.56 $41.1 Million - $86.3 Million	15,527,452 New	15,527,452 $74.8 Million

178

107M

330K

81.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $961M
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.